Mortality in Patients With Giant Cell Arteritis: A Cohort Study in UK Primary Care

Arthritis Care and Research

Volumn 70, Issue 8, 2018, Pages 1251-1256

  Li, Lin ^a,b   Neogi, Tuhina ^c   Jick, Susan ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ALL CAUSE MORTALITY; ARTICLE; ASTHMA; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DYSLIPIDEMIA; FEMALE; GIANT CELL ARTERITIS; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MORTALITY RISK; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PROPORTIONAL HAZARDS MODEL; RHEUMATOID ARTHRITIS; SEX; SMOKING; TRANSIENT ISCHEMIC ATTACK; UNDERWEIGHT; UNITED KINGDOM; VENOUS THROMBOEMBOLISM; CAUSE OF DEATH; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FACTUAL DATABASE; MORTALITY; PRIMARY HEALTH CARE; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTOR; SURVIVAL ANALYSIS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; GIANT CELL ARTERITIS; HUMANS; MALE; PRIMARY HEALTH CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; UNITED KINGDOM;

EID: 85047659144     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.23538     Document Type: Article

References (15)

1. Ninan J, Lester S, Hill C. Giant cell arteritis. Best Pract Res Clin Rheumatol 2016;30:169–88.
2. Pipitone N, Boiardi L, Bajocchi G, Salvarani C. Long-term outcome of giant cell arteritis. Clin Exp Rheumatol 2006;24 Suppl 41:S65–70.
3. Crow RW, Katz BJ, Warner JE, Alder SC, Zhang K, Schulman S, et al. Giant cell arteritis and mortality. J Gerontol A Biol Sci Med Sci 2009;64:365–9.
4. Hill CL, Black RJ, Nossent JC, Ruediger C, Nguyen L, Ninan JV, et al. Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Semin Arthritis Rheum 2017;46:513–9.
5. Li L, Neogi T, Jick S. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatology (Oxford) 2017;56:753–62.
6. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010;60:e128–36.
7. Dasgupta B, Borg FA, Hassan N, Alexander L, Barraclough K, Bourke B, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 2010;49:1594–7.
8. Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 2006;65:1093–8.
9. Catanoso M, Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A, et al. Incidence, prevalence, and survival of biopsy-proven giant cell arteritis in northern Italy during a 26-year period. Arthritis Care Res (Hoboken) 2017;69:430–8.
10. Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford) 2001;40:1238–42.
11. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996;100:193–6.
12. Ninan J, Nguyen AM, Cole A, Rischmueller M, Dodd T, Roberts-Thomson P, et al. Mortality in patients with biopsy-proven giant cell arteritis: a south Australian population-based study. J Rheumatol 2011;38:2215–7.
13. Baslund B, Helleberg M, Faurschou M, Obel N. Mortality in patients with giant cell arteritis. Rheumatology (Oxford) 2015;54:139–43.
14. Mohammad AJ, Nilsson JA, Jacobsson LT, Merkel PA, Turesson C. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Ann Rheum Dis 2015;74:993–7.
15. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989;299:549–50.